3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Motor Activity
22
Neoplasms
13
Breast Neoplasms
9
Lung Neoplasms
6
Pancreatic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Peripheral Nervous System Diseases
2
Obesity
2
Neoplasm Metastasis
2
Lymphoma
2
Lymphedema
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcopenia
1
Rectal Neoplasms
1
Quality of Life
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Neurotoxicity Syndromes
1
Neurocognitive Disorders
1
Neoplasms, Plasma Cell
1
Muscular Atrophy
1
Multiple Myeloma
1
Interventions
Paclitaxel
24
Bevacizumab
21
Carboplatin
20
liposomal doxorubicin
15
Specimen Handling
14
Magnetic Resonance Spectroscopy
13
olaparib
12
Gemcitabine
10
Topotecan
9
pembrolizumab
8
Biopsy
8
Taxes
7
Immunoglobulin G
6
Disulfides
6
niraparib
5
Doxorubicin
5
mirvetuximab soravtansine
4
cediranib
4
oregovomab
3
Nivolumab
3
Drug Therapy
3
Docetaxel
3
Cisplatin
3
sarilumab
2
rucaparib
2
cemiplimab
2
berzosertib
2
adavosertib
2
Saline Solution
2
Platinum
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
Exercise
×
90 days
×
Clear all
No trials found.